120 related articles for article (PubMed ID: 6600214)
1. Successful therapy of convoluted T-lymphoblastic lymphoma in the adult.
Levine AM; Forman SJ; Meyer PR; Koehler SC; Liebman H; Paganini-Hill A; Pockros A; Lukes RJ; Feinstein DI
Blood; 1983 Jan; 61(1):92-8. PubMed ID: 6600214
[TBL] [Abstract][Full Text] [Related]
2. Lymphoblastic lymphoma in adults: results of a pilot protocol.
Coleman CN; Cohen JR; Burke JS; Rosenberg SA
Blood; 1981 Apr; 57(4):679-84. PubMed ID: 6970598
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
Sullivan MP; Boyett J; Pullen J; Crist W; Doering EJ; Trueworthy R; Hvizdala E; Ruymann F; Steuber CP
Cancer; 1985 Jan; 55(2):323-36. PubMed ID: 3880656
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute lymphoblastic leukaemia (ALL).
Jacobs P; Wood L
Eur J Haematol; 1992 Aug; 49(2):53-8. PubMed ID: 1397240
[TBL] [Abstract][Full Text] [Related]
5. Results of LSA2-L2 therapy in 26 children with non-Hodgkin's lymphoma.
Pichler E; Jürgenssen OA; Radaszkiewicz T; Reinartz G; Mutz I; Urban C; Krepler P; Schmidmeier W; Becker H; Kundi M
Cancer; 1982 Dec; 50(12):2740-6. PubMed ID: 6897203
[TBL] [Abstract][Full Text] [Related]
6. Poor-risk non-lymphoblastic lymphoma of childhood: results of an intensive pilot study.
Finlay JL; Trigg ME; Link MP; Frierdich S
Med Pediatr Oncol; 1989; 17(1):29-38. PubMed ID: 2913472
[TBL] [Abstract][Full Text] [Related]
7. Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study.
Hvizdala EV; Berard C; Callihan T; Falletta J; Sabio H; Shuster JJ; Sullivan M; Wharam MD
J Clin Oncol; 1988 Jan; 6(1):26-33. PubMed ID: 3275750
[TBL] [Abstract][Full Text] [Related]
8. Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
Kung FH; Nythan WL; Cuttner J; Falkson G; Lanzkowsky P; Del Duca V; Nawabi IU; Koch K; Pluess H; Freeman A; Burgert EO; Leone LA; Ruymann F; Patterson RB; Degnan T; Hakami N; Pajak TF; Holland J
Cancer; 1978 Feb; 41(2):428-34. PubMed ID: 272945
[TBL] [Abstract][Full Text] [Related]
9. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
Patte C; Auperin A; Michon J; Behrendt H; Leverger G; Frappaz D; Lutz P; Coze C; Perel Y; Raphaël M; Terrier-Lacombe MJ;
Blood; 2001 Jun; 97(11):3370-9. PubMed ID: 11369626
[TBL] [Abstract][Full Text] [Related]
10. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].
Sun XF; Jiang WQ; Liu DG; Xia ZJ; Huang HQ; Zhang L; Li YH; Zhou ZM; Zhen ZJ; Xia Y; He YJ; Guan ZZ
Ai Zheng; 2004 Dec; 23(12):1687-91. PubMed ID: 15601561
[TBL] [Abstract][Full Text] [Related]
12. The chemotherapy of lymphoblastic lymphoma.
Voakes JB; Jones SE; McKelvey EM
Blood; 1981 Jan; 57(1):186-8. PubMed ID: 7448410
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).
Skarin AT; Rosenthal DS; Moloney WC; Frei E
Blood; 1977 May; 49(5):759-70. PubMed ID: 66957
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's lymphoma in children.
Wollner N; Burchenal JH; Lieberman PH; Exelby PR; D'Angio GJ; Murphy ML
Med Pediatr Oncol; 1975; 1(3):235-63. PubMed ID: 1232532
[TBL] [Abstract][Full Text] [Related]
15. Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study).
Pullen DJ; Sullivan MP; Falletta JM; Boyett JM; Humphrey GB; Starling KA; Land VJ; Dyment PG; Vats T; Duncan MH
Blood; 1982 Nov; 60(5):1159-68. PubMed ID: 6982085
[TBL] [Abstract][Full Text] [Related]
16. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study.
Sullivan MP; Chen T; Dyment PG; Hvizdala E; Steuber CP
Blood; 1982 Oct; 60(4):948-58. PubMed ID: 6956376
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of the APO protocol (vincristine, doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma.
Weinstein HJ; Cassady JR; Levey R
J Clin Oncol; 1983 Sep; 1(9):537-41. PubMed ID: 6689428
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
19. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
[TBL] [Abstract][Full Text] [Related]
20. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
